Cargando…

PSMA-PET for Lymph Node Detection in Recurrent Prostate Cancer: How do we use the Magic Bullet?

Detalles Bibliográficos
Autores principales:	Maurer, Tobias, Murphy, Declan G., Hofman, Michael S., Eiber, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479286/ https://www.ncbi.nlm.nih.gov/pubmed/28638485 http://dx.doi.org/10.7150/thno.20855

Ejemplares similares

Do You Believe in Magic (Bullets)?
por: French, Jacqueline A.
Publicado: (2020)

(68)Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
por: Rauscher, Isabel, et al.
Publicado: (2016)

The value of (68)Ga-PSMA enhanced PET-CT and MR-PET in patients with biochemical recurrent prostate cancer
por: Rummeny, E, et al.
Publicado: (2015)

Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support
por: Falkenbach, Fabian, et al.
Publicado: (2023)

Beyond the magic bullet
por: Lawrence, Christopher
Publicado: (1980)

The magic bullet: Niclosamide
por: Jiang, Haowen, et al.
Publicado: (2022)

Radioimmunotherapy of Non-Hodgkin’s Lymphoma: From the ‘Magic Bullets’ to ‘Radioactive Magic Bullets’
por: Chamarthy, Murthy R., et al.
Publicado: (2011)

A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients
por: Peeken, Jan C., et al.
Publicado: (2020)

Magic bullets, magic shields, and antimicrobials in between
por: Prathapan, Praveen
Publicado: (2023)

Diagnostic Accuracy of (18)F-PSMA-1007 PET/CT Imaging for Lymph Node Staging of Prostate Carcinoma in Primary and Biochemical Recurrence
por: Sprute, Katharina, et al.
Publicado: (2021)

Is radioimmunotherapy a 'magic bullet'?
por: Kim, Sung-Hyun
Publicado: (2012)

Oxytocin is needed, but it is no magic bullet
por: Weeks, AD
Publicado: (2016)

Magnetic Bead—Magic Bullet
por: Ruffert, Christine
Publicado: (2016)

PSMA-targeted imaging of prostate cancer: evolution of a success story
por: Maurer, Tobias, et al.
Publicado: (2017)

Development and external validation of a multivariable [(68)Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer
por: Muehlematter, Urs J., et al.
Publicado: (2023)

Temporary Reactive Response of Axillary Lymph Nodes to COVID-19 Vaccination on (18)F-rhPSMA-7.3 PET/CT in Patients with Prostate Cancer
por: Notohamiprodjo, Susan, et al.
Publicado: (2022)

Artemisinin Antimalarials: Preserving the “Magic Bullet”
por: Maude, Richard J, et al.
Publicado: (2010)

Nanobody: The “Magic Bullet” for Molecular Imaging?
por: Chakravarty, Rubel, et al.
Publicado: (2014)

Inaugural Editorial: Searching for Magic Bullets
por: Ho, Mitchell
Publicado: (2018)

Nanocarriers as Magic Bullets in the Treatment of Leukemia
por: Houshmand, Mohammad, et al.
Publicado: (2020)

Passive Immunization: Toward Magic Bullets
por: Marcotte, Harold, et al.
Publicado: (2015)

Mesorectal Lymph Node Metastases as Index Lesion in (68)Ga-PSMA-PET/CT Imaging for Recurrent Prostate Cancer
por: Leitsmann, Conrad, et al.
Publicado: (2021)

Accuracy of (68)Ga-PSMA PET-CT and PET-MRI in lymph node staging for localized prostate cancer
por: Barbosa, Álan Roger Gomes, et al.
Publicado: (2022)

Pre-test (68)Ga-PSMA-ligand PET/CT positivity in early biochemical recurrent prostate cancer after radical prostatectomy—validation of a prediction model
por: Kraft, Pia, et al.
Publicado: (2020)

Magic bullet: the history of oral rehydration therapy.
por: Ruxin, J N
Publicado: (1994)

Is metabolism the magic bullet for targeted cancer therapy?
por: Trajkovic-Arsic, Marija, et al.
Publicado: (2023)

Malaria: moving beyond the search for magic bullets
por: Levashina, Elena, et al.
Publicado: (2023)

[(111)In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery
por: Schottelius, Margret, et al.
Publicado: (2015)

The added value of PSMA PET/MR radiomics for prostate cancer staging
por: Solari, Esteban Lucas, et al.
Publicado: (2021)

EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate Cancer
por: Falkenbach, Fabian, et al.
Publicado: (2023)

Hydroxylamine Analogue of Agmatine: Magic Bullet for Arginine Decarboxylase
por: Hyvönen, Mervi T., et al.
Publicado: (2020)

Anti-TNF, a magic bullet in cancer immunotherapy?
por: Montfort, Anne, et al.
Publicado: (2019)

Adiponectin and the Control of Metabolic Dysfunction: Is Exercise the Magic Bullet?
por: Otu, Lauretta I., et al.
Publicado: (2021)

Breast milk stem cells: Are they magic bullets in neonatology?
por: Kersin, Sinem Gülcan, et al.
Publicado: (2021)

Liver gene therapy: The magic bullet for the sick lung
por: Brunetti-Pierri, Nicola
Publicado: (2022)

Integration of (68)Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study
por: Dewes, Sabrina, et al.
Publicado: (2016)

Salvage lymph node dissection after (68)Ga-PSMA or (18)F-FEC PET/CT for nodal recurrence in prostate cancer patients
por: Herlemann, Annika, et al.
Publicado: (2017)

Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer
por: Jilg, Cordula A., et al.
Publicado: (2017)

Risk Factors for Biochemical Recurrence After PSMA-PET-Guided Definitive Radiotherapy in Patients With De Novo Lymph Node-Positive Prostate Cancer
por: Spohn, Simon K.B., et al.
Publicado: (2022)

E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
por: Ceci, Francesco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_la4pa4qhh445biqk834516ooog